Uninsured With Brain Tumors Have Higher Post-Op Mortality

This article originally appeared here.
Share this content:
Uninsured With Brain Tumors Have Higher Post-Op Mortality
Uninsured With Brain Tumors Have Higher Post-Op Mortality

Uninsured patients undergoing a craniotomy procedure for a brain tumor have higher in-hospital postoperative mortality rates than insured patients, according to research published in the November issue of the Archives of Surgery.

Eric N. Momin, M.D., of the Johns Hopkins University School of Medicine in Baltimore, and colleagues conducted a retrospective cohort study using data from the Nationwide Inpatient Sample involving 28,581 patients, aged 18 to 65 years, who underwent craniotomy procedures for a brain tumor. The association between in-hospital postoperative death and insurance status was examined for the full cohort and for a subset of patients with no comorbidity.

In unadjusted analysis, the researchers found that the mortality rates were 1.3 percent for privately insured patients, 2.6 percent for uninsured patients, and 2.3 percent for Medicare patients. After adjustment for patient characteristics and stratification by hospital for patients without comorbidity, the risk of in-hospital death was still significantly higher among uninsured patients (hazard ratio, 2.62) compared with privately insured patients. After adjustment, the risk of in-hospital mortality was non-significantly higher for Medicare patients (hazard ratio, 2.03; P = 0.06).

"Uninsured patients undergoing craniotomy for a brain tumor experience worse outcomes than privately insured patients, and this difference is pronounced in teaching hospitals," the authors write. "This variation in postoperative outcomes remains unexplained by hospital characteristics, including clustering effects, comorbid disease, or socioeconomic variations."


Full Text (subscription or payment may be required)

Editorial (subscription or payment may be required)

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs